U.S. Specialty Stores Stock News

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

If you are wondering whether Innoviva's current share price lines up with its underlying worth, you are not alone. That is exactly what this article aims to unpack. Innoviva shares last closed at US$19.65, with returns of a 1.7% decline over 7 days, a 5.1% decline over 30 days, a 1.1% decline year to date, and gains of 13.5% over 1 year, 44.5% over 3 years, and 52.7% over 5 years that may have shifted how investors think about its potential and risk. Recent news around Innoviva has focused...

This week we saw the Shoe Carnival, Inc. ( NASDAQ:SCVL ) share price climb by 12%. But that is minimal compensation for...

In late December 2025, ARS Pharmaceuticals announced that China’s National Medical Products Administration approved neffy 2 mg epinephrine nasal spray, branded 优敏速®, for emergency treatment of Type 1 allergic reactions in adults and children weighing at least 30 kg. This approval gives ARS Pharmaceuticals access to a Chinese population where tens of millions are estimated to be at risk of severe food allergy reactions, with a pediatric 1 mg filing planned to further expand the addressable...

Choice Hotels International (CHH) has attracted fresh attention after a recent rebound in its share price, with the stock showing gains over the past week, month, and past 3 months that contrast with its 1 year decline. See our latest analysis for Choice Hotels International. That rebound comes after a tougher stretch, with the 1 year total shareholder return at a 24.1% decline. However, the recent 30 day share price return of 25% suggests momentum has picked up again from a lower base. If...

If you are wondering whether Expeditors International of Washington at around US$158 per share is offering fair value or not, you are in the right place for a clear valuation checkup. The stock has recently recorded returns of 6.1% over 7 days, 7.1% over 30 days, 4.1% year to date, 41.8% over 1 year, 48.6% over 3 years, and 77.3% over 5 years, which may catch the eye of investors thinking about growth potential or changing risk perceptions. These moves are occurring against a backdrop where...

Key Insights The projected fair value for Linde is US$390 based on 2 Stage Free Cash Flow to Equity With US$440 share...

Why flyExclusive’s Starlink deal is catching investor attention flyExclusive (FLYX) has drawn fresh attention after signing an authorized dealership agreement with Starlink, pairing that connectivity deal with the ongoing expansion of its maintenance offerings and broader growth initiatives in North Carolina. See our latest analysis for flyExclusive. The recent Starlink dealership, new Raleigh office and follow-on equity filing come alongside a sharp rebound in sentiment, with a 30 day share...

In early January 2026, MIPS, a GlobalFoundries company, announced the MIPS S8200 RISC-V NPU processor IP for advanced AI workloads at the edge, alongside ForwardEdge ASIC’s selection of this IP for a high-performance autonomous platforms ASIC. This pairing of a next-generation edge AI design and an early Lockheed Martin–linked customer highlights how GlobalFoundries’ MIPS acquisition is feeding into real embedded AI demand. We’ll now examine how the new MIPS S8200 edge AI processor win,...

The Morning Bull - US Market Morning Update Friday, Jan, 9 2026 US stock futures are slightly softer this morning, with S&P 500 contracts edging down about 0.1%, as investors focus on a cooling US jobs backdrop and strong global trade signals from Asia. Non-farm payrolls are expected to show around 60,000 new jobs in December, with unemployment at 4.5% and wages up 0.3% month on month, which effectively means pay is growing, but not rapidly. At the same time, Taiwan’s exports jumped 43.4% YoY...

The board of Lincoln National Corporation ( NYSE:LNC ) has announced that it will pay a dividend on the 2nd of...

VSE Corporation's ( NASDAQ:VSEC ) price-to-earnings (or "P/E") ratio of 79.5x might make it look like a strong sell...

O-I Glass (OI) has moved back into focus after a series of upbeat analyst calls, as Wells Fargo, Truist Securities and Citi all raised their expectations, citing cost savings and improved margins despite macro headwinds. See our latest analysis for O-I Glass. The recent wave of analyst upgrades has landed on a share price of US$15.33 that is already backed by firm momentum, with a 90 day share price return of 31.81% and a 1 year total shareholder return of 46.70%, even though the 3 year total...

Transcat (NASDAQ:TRNS) has had a great run on the share market with its stock up by a significant 21% over the last...

In early January 2026, MarketAxess reported that transaction fees declined in December and the fourth quarter of 2025, largely due to a shift in the mix of trading protocols on its electronic bond trading platform. This fee pressure, alongside a long-running decline in gross and operating margins, has sharpened investor focus on the resilience of the company’s profitability model as its business mix evolves. We’ll now examine how the recent decline in transaction fees per million traded...

Teekay Tankers (TNK) is back on investor radar after recent share price moves, with the stock around $59.10 and trailing 1 year total return data and revenue figures providing a fresh basis for comparison. See our latest analysis for Teekay Tankers. The recent move in Teekay Tankers’ share price to around $59.10 comes after a strong 7 day share price return of 10.63% and a 90 day share price return of 20.29%, while the 1 year total shareholder return of 46.58% and very large 5 year total...

In recent days, Rollins Inc. saw its short interest as a percentage of float ease to 3.16%, while Executive Chairman John F. Wilson sold 1,520 shares to meet tax withholding obligations tied to restricted stock vesting. At the same time, multiple major analysts upgraded Rollins with positive views on demand and growth potential, signaling rising confidence in the company’s position relative to peers with higher short interest. Next, we’ll examine how these upbeat analyst upgrades, paired...

Olin Corporation has recently cut its fourth quarter 2025 outlook, now expecting adjusted EBITDA of about US$67 million after operational issues at its Freeport, Texas chlor-alkali and vinyls facility and softer pipeline chlorine demand. This guidance revision highlights how operational reliability at key sites and demand volatility in core chlor-alkali markets can quickly influence Olin’s earnings profile. We’ll now examine how this weaker Q4 EBITDA guidance, driven largely by Freeport...

Sturm, Ruger & Company, Inc. ( NYSE:RGR ) shareholders should be happy to see the share price up 13% in the last month...

Impinj, Inc. ( NASDAQ:PI ) shareholders would be excited to see that the share price has had a great month, posting a...

Immunome recently granted stock options to three new hires under its 2024 Inducement Plan and highlighted strong Phase 3 RINGSIDE data for its lead cancer drug candidate, varegacestat, while also scheduling a presentation at the 44th Annual J.P. Morgan Healthcare Conference. Together, the positive clinical results, upcoming New Drug Application plans for varegacestat, and new equity-based hiring incentives underscore Immunome’s efforts to build a pipeline and team around its late-stage...

If you are wondering whether Martin Marietta Materials is priced attractively right now, the key question is how its current share price lines up against what you think the business is worth. The stock last closed at US$638.11, with returns of 2.5% over 7 days, 4.3% over 30 days, 0.6% year to date, 24.1% over 1 year, 84.8% over 3 years and 117.4% over 5 years. This naturally raises questions about the balance between opportunity and risk at today’s level. Recent attention on US...

If you are wondering whether Amphastar Pharmaceuticals' current share price reflects its true worth, you are not alone. This article is designed to help you assess that. The stock last closed at US$27.74, with returns of 3.6% over the past week, 8.1% over the past month, 4.8% year to date and a 24.3% decline over the past year, alongside a 44.0% gain over five years. Recent attention on Amphastar Pharmaceuticals has been shaped by ongoing discussions around its product portfolio and position...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...